Eli Lilly Drug Test Result; AbbVie Beat; WBD Layoffs
On this episode of Stock Movers:- Eli Lilly (LLY) shares are moving on news the company's diabetes drug Mounjaro was as good at preventing heart attacks and strokes as its older medicine Trulicity in a head-to-head study. According to Bloomberg Intelligence analyst Michael Shah, the study's results will "likely be received negatively by the market" because Mounjaro was not meaningfully better than Trulicity.- AbbVie (ABBV) shares are getting a lift after AbbVie raised its full-year profit forecast due to booming sales from newer immunology drugs that beat Wall Street's estimates. The…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.